Evidence map›Paper›PMID 32170603›Full record

ArticleInflammation2020

Esculetin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Modulation of the AKT/ERK/NF-κB and RORγt/IL-17 Pathways.

Hung-Chen Lee, Fu-Chao Liu, Chi-Neu Tsai, An-Hsun Chou, Chia-Chih Liao, Huang-Ping Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Journal of microbiology and biotechnology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. NMDA receptor modulation by Esculetin: Investigating behavioral, biochemical and neurochemical effects in schizophrenic mice model.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in endocrinology · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hung-Chen LeeDepartment of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Fu-Chao LiuDepartment of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chi-Neu TsaiGraduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
An-Hsun ChouDepartment of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chia-Chih LiaoDepartment of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Huang-Ping YuDepartment of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan. yuhp2001@adm.cgmh.org.tw.ORCID http://orcid.org/0000-0002-3030-0560
Chang Gung University · TW

Funding

Chang Gung Memorial Hospital, Linkou CMRPG3G1601-2Chang Gung Memorial Hospital, Linkou CMRPG3H0811-3, CMRPG3H1191-3Ministry of Science and Technology, Taiwan MOST105-2314-B-182A-012-MY3Ministry of Science and Technology, Taiwan MOST105-2314-B-182A-137-MY3
6 · The paper itself

Abstract

Esculetin, a coumarin derivative from various natural plants, has an anti-inflammatory property. In the present study, we examined if esculetin has any salutary effects against lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. Acute lung injury (ALI) was induced via the intratracheal administration of LPS, and esculetin (20 and 40 mg/kg) was given intraperitoneally 30 min before LPS challenge. After 6 h of LPS administration, lung tissues were collected for analysis. Pretreatment with esculetin significantly attenuated histopathological changes, inflammatory cell infiltration, and production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, in the lung tissue. Furthermore, esculetin inhibited the protein kinase B (AKT), extracellular signal-regulated kinase (ERK), and nuclear factor-kappa B (NF-κB) pathways and downregulated the expression of RORγt and IL-17 in LPS-induced ALI. Our results indicated that esculetin possesses anti-inflammatory and protective effects against LPS-induced ALI via inhibition of the AKT/ERK/NF-κB and RORγt/IL-17 pathways.

Indexed as

Acute Lung InjuryAnimalsAntioxidantsDose-Response Relationship, DrugInterleukin-17LipopolysaccharidesMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLNF-kappa BNuclear Receptor Subfamily 1, Group F, Member 3Proto-Oncogene Proteins c-aktUmbelliferonesAntioxidantsesculetinIl17a protein, mouseInterleukin-17LipopolysaccharidesNF-kappa BNuclear Receptor Subfamily 1, Group F, Member 3Proto-Oncogene Proteins c-aktRorc protein, mouseUmbelliferonesAKT/ERK/NF-κBesculetinLPSlung injuryRORγt/IL-17

Identifiers

PMID32170603
OpenAlexW3011362003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.